title: Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.
abstract: RePORT International is a collaborative research network of investigators from multiple countries and institutions with the goal of establishing a bio-repository of specimens and clinical data for the study of active TB and latent TB infection (LTBI). During the first meeting of RePORT International in Boston, Massachusetts, the results of research pertinent to TB control and eradication were presented, including advances in the research of Mycobacterium tuberculosis (MTB) persistence and drug resistance, TB diagnostics, drug and vaccine development.
authors.affiliation: Boston Medical Center and Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases, Boston, MA, USA.
authors.forename: Carolina
authors.initials: C
authors.lastname: Geadas
authors.affiliation: Health Studies Sector, Westat, Rockville, MD, USA.
authors.forename: Sonia K
authors.initials: SK
authors.lastname: Stoszek
authors.affiliation: Center for Infectious Disease Research, Seattle, WA, USA.
authors.forename: David
authors.initials: D
authors.lastname: Sherman
authors.affiliation: Unidade de Medicina Investigativa, Laboratório Integrado de Microbiologia e Imunorregulação, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
authors.forename: Bruno B
authors.initials: BB
authors.lastname: Andrade
authors.affiliation: Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Sudha
authors.initials: S
authors.lastname: Srinivasan
authors.affiliation: Scientific Affairs, Global Health, Population and Nutrition, FHI 360, Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA.
authors.forename: Carol D
authors.initials: CD
authors.lastname: Hamilton
authors.affiliation: Boston Medical Center and Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases, Boston, MA, USA. Electronic address: Jerrold.Ellner@bmc.org.
authors.forename: Jerrold
authors.initials: J
authors.lastname: Ellner
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use; D035843:Biomedical Research / Q000379:methods / Q000639:trends*; D055808:Drug Discovery / Q000379:methods / Q000639:trends; D024881:Drug Resistance, Bacterial; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D057170:Translational Research, Biomedical / Q000379:methods / Q000639:trends; D014376:Tuberculosis / Q000175:diagnosis / Q000517:prevention & control*; D032581:Tuberculosis Vaccines
chemical_list: D000995:Antitubercular Agents; D032581:Tuberculosis Vaccines
keywords: Advances; RePORT; Research; Tuberculosis